$4.76 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 133 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 79.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | INVITAE CORPnote 2.000% 9/0 | $245,760,000 | – | 163,385,000 | +100.0% | 5.16% | – | |
| VTRS | Buy | VIATRIS INC | $240,619,000 | -18.3% | 17,224,000 | +9.5% | 5.06% | -13.2% |
| NEVRO CORPnote 1.750% 6/0 | $168,437,000 | -19.2% | 115,776,000 | 0.0% | 3.54% | -14.1% | ||
| New | AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $154,446,000 | – | 149,600,000 | +100.0% | 3.25% | – | |
| New | BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $131,952,000 | – | 80,000,000 | +100.0% | 2.77% | – | |
| EWTX | New | EDGEWISE THERAPEUTICS INC | $127,827,000 | – | 3,933,137 | +100.0% | 2.69% | – |
| CNC | Sell | CENTENE CORP DEL | $126,901,000 | -13.0% | 1,985,619 | -18.3% | 2.67% | -7.5% |
| BSX | New | BOSTON SCIENTIFIC CORP | $110,423,000 | – | 2,857,000 | +100.0% | 2.32% | – |
| DFPH | Buy | DFP HEALTHCARE ACQUISITNS CO | $104,182,000 | +76.7% | 10,460,000 | +91.6% | 2.19% | +87.9% |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $88,573,000 | – | 579,248 | +100.0% | 1.86% | – |
| BIIB | Sell | BIOGEN INC | $86,723,000 | -20.9% | 310,000 | -30.8% | 1.82% | -15.9% |
| AHCO | Buy | ADAPTHEALTH CORP | $83,735,000 | +23.4% | 2,277,871 | +26.1% | 1.76% | +31.2% |
| DFHT | Buy | DEERFIELD HEALTHCARE TECH AC | $82,158,000 | +54.0% | 6,778,750 | +98.3% | 1.73% | +63.9% |
| PCRX | Buy | PACIRA BIOSCIENCES INC | $81,653,000 | +30.0% | 1,164,973 | +11.0% | 1.72% | +38.3% |
| New | INSULET CORPnote 0.375% 9/0 | $76,117,000 | – | 57,581,000 | +100.0% | 1.60% | – | |
| LRMR | LARIMAR THERAPEUTICS INC | $75,162,000 | -31.8% | 5,144,539 | 0.0% | 1.58% | -27.4% | |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $70,506,000 | – | 725,000 | +100.0% | 1.48% | – |
| MIRM | MIRUM PHARMACEUTICALS INC | $68,357,000 | +13.5% | 3,448,912 | 0.0% | 1.44% | +20.8% | |
| New | INSMED INCnote 1.750% 1/1 | $67,986,000 | – | 61,000,000 | +100.0% | 1.43% | – | |
| RVMD | Buy | REVOLUTION MEDICINES INC | $65,916,000 | +19.2% | 1,436,712 | +2.9% | 1.38% | +26.7% |
| CYTK | Buy | CYTOKINETICS INC | $59,569,000 | +16.5% | 2,561,000 | +4.1% | 1.25% | +23.8% |
| OMI | Buy | OWENS & MINOR INC NEW | $58,227,000 | +96.4% | 1,549,000 | +41.3% | 1.22% | +108.9% |
| AFIB | ACUTUS MED INC | $58,050,000 | -53.6% | 4,341,799 | 0.0% | 1.22% | -50.6% | |
| ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $57,149,000 | +290.4% | 357,000 | +275.8% | 1.20% | +315.6% |
| ORGO | New | ORGANOGENESIS HLDGS INC | $54,581,000 | – | 2,995,638 | +100.0% | 1.15% | – |
| MOH | Buy | MOLINA HEALTHCARE INC | $54,180,000 | +103.8% | 231,776 | +85.4% | 1.14% | +117.0% |
| TERN | New | TERNS PHARMACEUTICALS INC | $51,611,000 | – | 2,345,959 | +100.0% | 1.08% | – |
| ATEC | Buy | ALPHATEC HLDGS INC | $50,558,000 | +74.1% | 3,201,916 | +60.1% | 1.06% | +85.2% |
| ORTX | ORCHARD THERAPEUTICS PLCads | $50,453,000 | +68.1% | 6,949,416 | 0.0% | 1.06% | +78.8% | |
| New | INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $47,537,000 | – | 57,791,000 | +100.0% | 1.00% | – | |
| New | CLOVIS ONCOLOGY INCnote 2.500% 9/1 | $46,323,000 | – | 49,064,000 | +100.0% | 0.97% | – | |
| OCDX | New | ORTHO CLINICAL DIAGNOSTICS H | $45,400,000 | – | 2,352,941 | +100.0% | 0.95% | – |
| BKD | Sell | BROOKDALE SR LIVING INC | $45,320,000 | -7.2% | 7,490,845 | -32.0% | 0.95% | -1.3% |
| New | TABULA RASA HEALTHCARE INCnote 1.750% 2/1 | $44,718,000 | – | 45,000,000 | +100.0% | 0.94% | – | |
| ONCR | Buy | ONCORUS INC | $43,834,000 | -52.4% | 3,148,977 | +10.5% | 0.92% | -49.4% |
| LUNG | Buy | PULMONX CORP | $42,860,000 | +34.0% | 937,032 | +102.2% | 0.90% | +42.6% |
| RYTM | Sell | RHYTHM PHARMACEUTICALS INC | $42,319,000 | -47.7% | 1,989,625 | -26.9% | 0.89% | -44.4% |
| RETA | Buy | REATA PHARMACEUTICALS INCcl a | $41,874,000 | +5.9% | 420,000 | +31.2% | 0.88% | +12.5% |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $41,094,000 | -60.7% | 558,574 | -61.3% | 0.86% | -58.2% |
| New | NOVAVAX INCnote 3.750% 2/0 | $41,054,000 | – | 25,000,000 | +100.0% | 0.86% | – | |
| New | NUVASIVE INCnote 0.375% 3/1 | $40,857,000 | – | 40,000,000 | +100.0% | 0.86% | – | |
| CNST | Buy | CONSTELLATION PHARMCETICLS I | $39,973,000 | -4.9% | 1,708,957 | +17.1% | 0.84% | +1.2% |
| INZY | Buy | INOZYME PHARMA INC | $38,887,000 | +63.8% | 1,964,000 | +70.7% | 0.82% | +74.2% |
| BDSI | BIODELIVERY SCIENCES INTL IN | $37,262,000 | -6.9% | 9,530,000 | 0.0% | 0.78% | -1.0% | |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $36,642,000 | -9.8% | 3,769,795 | -4.8% | 0.77% | -4.1% |
| ISEE | IVERIC BIO INC | $35,643,000 | -10.6% | 5,767,409 | 0.0% | 0.75% | -4.9% | |
| APR | New | APRIA INC | $33,516,000 | – | 1,200,000 | +100.0% | 0.70% | – |
| PTGX | Sell | PROTAGONIST THERAPEUTICS INC | $32,603,000 | +17.2% | 1,258,790 | -8.8% | 0.68% | +24.5% |
| NUVB | New | NUVATION BIO INC | $31,350,000 | – | 3,000,000 | +100.0% | 0.66% | – |
| HRC | New | HILL ROM HLDGS INC | $30,920,000 | – | 279,870 | +100.0% | 0.65% | – |
| New | APELLIS PHARMACEUTICALS INCnote 3.500% 9/1 | $30,574,000 | – | 21,825,000 | +100.0% | 0.64% | – | |
| XERIS PHARMACEUTICALS INCnote 5.000% 7/1 | $30,417,000 | -3.9% | 18,000,000 | 0.0% | 0.64% | +2.1% | ||
| XLRN | Sell | ACCELERON PHARMA INC | $29,766,000 | -44.8% | 219,500 | -47.9% | 0.63% | -41.3% |
| XERS | New | XERIS PHARMACEUTICALS INC | $29,556,000 | – | 6,553,398 | +100.0% | 0.62% | – |
| GRAY | GRAYBUG VISION INC | $29,314,000 | -80.9% | 5,281,713 | 0.0% | 0.62% | -79.7% | |
| PHVS | New | PHARVARIS N V | $28,897,000 | – | 1,032,757 | +100.0% | 0.61% | – |
| ITMR | Buy | ITAMAR MED LTDsponsored ads | $28,592,000 | +81.4% | 1,193,803 | +50.4% | 0.60% | +92.6% |
| TIL | New | INSTIL BIO INC | $27,983,000 | – | 1,115,739 | +100.0% | 0.59% | – |
| SHC | SOTERA HEALTH CO | $27,731,000 | -9.0% | 1,111,000 | 0.0% | 0.58% | -3.3% | |
| FOLD | New | AMICUS THERAPEUTICS INC | $26,661,000 | – | 2,698,497 | +100.0% | 0.56% | – |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS | $26,497,000 | -39.1% | 2,605,380 | -55.4% | 0.56% | -35.2% |
| KALV | New | KALVISTA PHARMACEUTICALS INC | $26,204,000 | – | 1,020,005 | +100.0% | 0.55% | – |
| PROF | Buy | PROFOUND MED CORP | $26,138,000 | +82.9% | 1,297,797 | +86.7% | 0.55% | +94.7% |
| GBIO | Sell | GENERATION BIO CO | $25,551,000 | -6.2% | 897,779 | -6.6% | 0.54% | -0.4% |
| BDTX | Buy | BLACK DIAMOND THERAPEUTICS I | $25,415,000 | -1.2% | 1,047,599 | +30.5% | 0.53% | +5.1% |
| FATE | New | FATE THERAPEUTICS INC | $25,065,000 | – | 304,000 | +100.0% | 0.53% | – |
| SILK | Buy | SILK RD MED INC | $24,745,000 | +247.7% | 488,545 | +332.3% | 0.52% | +268.8% |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $23,708,000 | -9.0% | 2,404,439 | 0.0% | 0.50% | -3.3% | |
| DCPH | DECIPHERA PHARMACEUTICALS IN | $23,702,000 | -21.4% | 528,585 | 0.0% | 0.50% | -16.4% | |
| VIVO | Sell | MERIDIAN BIOSCIENCE INC | $23,343,000 | -42.2% | 889,269 | -58.8% | 0.49% | -38.5% |
| ALEC | ALECTOR INC | $21,252,000 | +33.1% | 1,055,192 | 0.0% | 0.45% | +41.5% | |
| MAACU | MONTES ARCHIMEDES ACQUISITIOunit 09/30/2025 | $20,400,000 | -2.9% | 2,000,000 | 0.0% | 0.43% | +3.4% | |
| BPMC | New | BLUEPRINT MEDICINES CORP | $20,321,000 | – | 209,000 | +100.0% | 0.43% | – |
| WVE | New | WAVE LIFE SCIENCES LTD | $19,652,000 | – | 3,502,970 | +100.0% | 0.41% | – |
| NEVRO CORPnote 2.750% 4/0 | $18,208,000 | -16.9% | 12,000,000 | 0.0% | 0.38% | -11.5% | ||
| CMRX | New | CHIMERIX INC | $17,508,000 | – | 1,816,221 | +100.0% | 0.37% | – |
| AMWL | Buy | AMERICAN WELL CORPcl a | $17,216,000 | -14.1% | 991,115 | +25.3% | 0.36% | -8.6% |
| ARDX | ARDELYX INC | $16,957,000 | +2.3% | 2,561,554 | 0.0% | 0.36% | +8.5% | |
| PTC THERAPEUTICS INCnote 3.000% 8/1 | $16,688,000 | -10.2% | 14,527,000 | 0.0% | 0.35% | -4.4% | ||
| CERT | CERTARA INC | $16,380,000 | -19.0% | 600,000 | 0.0% | 0.34% | -14.0% | |
| ANNX | Sell | ANNEXON INC | $16,256,000 | -44.4% | 583,913 | -50.0% | 0.34% | -40.8% |
| MDVL | MEDAVAIL HOLDINGS INC | $15,996,000 | -7.0% | 1,142,552 | 0.0% | 0.34% | -1.2% | |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $15,589,000 | +4.5% | 468,000 | -18.6% | 0.33% | +11.2% |
| BVS | New | BIOVENTUS INC | $14,623,000 | – | 957,000 | +100.0% | 0.31% | – |
| RUBY | New | RUBIUS THERAPEUTICS INC | $14,575,000 | – | 550,000 | +100.0% | 0.31% | – |
| BLUE | New | BLUEBIRD BIO INC | $14,481,000 | – | 480,300 | +100.0% | 0.30% | – |
| SYK | STRYKER CORPORATION | $14,371,000 | -0.6% | 59,000 | 0.0% | 0.30% | +5.6% | |
| PMVP | Buy | PMV PHARMACEUTICALS INC | $13,935,000 | +21.0% | 423,680 | +126.3% | 0.29% | +28.5% |
| ACHL | New | ACHILLES THERAPEUTICS PLCsponsored ads | $13,240,000 | – | 800,000 | +100.0% | 0.28% | – |
| CAPAU | HIGHCAPE CAP ACQUISITION CORunit 09/30/2027 | $12,920,000 | +25.2% | 1,000,000 | 0.0% | 0.27% | +33.3% | |
| AUTL | New | AUTOLUS THERAPEUTICS PLCspon ads | $12,279,000 | – | 2,142,857 | +100.0% | 0.26% | – |
| SGFY | New | SIGNIFY HEALTH INC | $11,704,000 | – | 400,000 | +100.0% | 0.25% | – |
| BOLT | New | BOLT BIOTHERAPEUTICS INC | $11,519,000 | – | 350,000 | +100.0% | 0.24% | – |
| STIM | NEURONETICS INC | $11,368,000 | +11.3% | 919,000 | 0.0% | 0.24% | +18.3% | |
| WOOF | New | PETCO HEALTH & WELLNESS CO I | $11,080,000 | – | 500,000 | +100.0% | 0.23% | – |
| SRSAU | SARISSA CAPITAL ACQUISITN COunit 10/23/2027 | $10,830,000 | +1.7% | 1,000,000 | 0.0% | 0.23% | +8.6% | |
| KNTE | KINNATE BIOPHARMA INC | $10,750,000 | -21.7% | 345,000 | 0.0% | 0.23% | -16.6% | |
| DYN | Buy | DYNE THERAPEUTICS INC | $10,654,000 | -11.0% | 686,000 | +20.4% | 0.22% | -5.5% |
| BCAB | Sell | BIOATLA INC | $10,444,000 | +9.5% | 205,422 | -26.7% | 0.22% | +16.5% |
| MTACU | MEDTECH ACQUISITION CORPunit 12/18/2025 | $10,050,000 | -4.3% | 1,000,000 | 0.0% | 0.21% | +1.4% | |
| REVHU | New | REVOLUTION HEALTHCAR AQ CORPunit 03/18/20266 | $10,054,000 | – | 1,000,000 | +100.0% | 0.21% | – |
| SNRHU | SENIOR CONNECT ACQUISITN CORunit 12/09/2023 | $10,010,000 | -2.7% | 1,000,000 | 0.0% | 0.21% | +3.4% | |
| EUCRU | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $10,012,000 | -6.1% | 1,000,000 | 0.0% | 0.21% | -0.5% | |
| RNA | AVIDITY BIOSCIENCES INC | $9,901,000 | -14.5% | 453,973 | 0.0% | 0.21% | -9.2% | |
| OLMA | Sell | OLEMA PHARMACEUTICALS INC | $8,998,000 | -73.1% | 271,191 | -61.0% | 0.19% | -71.5% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $8,832,000 | -43.7% | 494,216 | -57.5% | 0.19% | -40.0% |
| COGT | COGENT BIOSCIENCES INC | $8,780,000 | -21.8% | 1,000,000 | 0.0% | 0.18% | -16.7% | |
| TPTX | TURNING POINT THERAPEUTICS I | $7,931,000 | -22.4% | 83,846 | 0.0% | 0.17% | -17.3% | |
| INNV | New | INNOVAGE HLDG CORP | $7,737,000 | – | 300,000 | +100.0% | 0.16% | – |
| CMIIU | New | CM LIFE SCIENCES II INCunit 02/25/2028 | $7,680,000 | – | 600,000 | +100.0% | 0.16% | – |
| TMPMU | TURMERIC ACQUISITION CORPunit 10/08/2025 | $7,500,000 | -2.6% | 750,000 | 0.0% | 0.16% | +3.9% | |
| IMCR | New | IMMUNOCORE HLDGS PLCads | $7,318,000 | – | 171,908 | +100.0% | 0.15% | – |
| IGNYU | New | IGNYTE ACQUISITION CORPunit 01/05/2026 | $7,265,000 | – | 725,000 | +100.0% | 0.15% | – |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $6,507,000 | +4.6% | 150,000 | 0.0% | 0.14% | +11.4% | |
| DCTH | DELCATH SYS INC | $6,210,000 | -30.7% | 500,000 | 0.0% | 0.13% | -26.0% | |
| GRCL | New | GRACELL BIOTECHNOLOGIES INCsponsored ads | $6,160,000 | – | 400,000 | +100.0% | 0.13% | – |
| New | BENEFITFOCUS INCnote 1.250%12/1 | $5,936,000 | – | 6,500,000 | +100.0% | 0.12% | – | |
| SNSE | New | SENSEI BIOTHERAPEUTICS INC | $5,449,000 | – | 375,000 | +100.0% | 0.12% | – |
| XENT | INTERSECT ENT INC | $5,334,000 | -8.8% | 255,456 | 0.0% | 0.11% | -3.4% | |
| CABA | CABALETTA BIO INC | $5,153,000 | -11.1% | 464,252 | 0.0% | 0.11% | -6.1% | |
| OHPAU | New | ORION ACQUISITION CORPunit 02/19/2026 | $5,000,000 | – | 500,000 | +100.0% | 0.10% | – |
| CHFWU | CONSONANCE HFW ACQUISITION Cunit 99/99/9999 | $4,880,000 | -6.8% | 500,000 | 0.0% | 0.10% | 0.0% | |
| BFLYWS | New | BUTTERFLY NETWORK INC*w exp 05/27/202 | $4,730,000 | – | 733,333 | +100.0% | 0.10% | – |
| LUMO | Sell | LUMOS PHARMA INC | $4,365,000 | -86.9% | 373,117 | -60.1% | 0.09% | -86.1% |
| LABP | New | LANDOS BIOPHARMA INC | $4,334,000 | – | 450,000 | +100.0% | 0.09% | – |
| New | NEOGENOMICS INCnote 0.250% 1/1 | $2,524,000 | – | 2,500,000 | +100.0% | 0.05% | – | |
| MTCR | METACRINE INC | $1,720,000 | -21.1% | 277,469 | 0.0% | 0.04% | -16.3% | |
| DFPHW | New | DFP HEALTHCARE ACQUISITNS CO*w exp 03/31/202 | $1,688,000 | – | 1,250,000 | +100.0% | 0.04% | – |
| DFHTW | New | DEERFIELD HEALTHCARE TECH AC*w exp 07/16/202 | $1,552,000 | – | 672,000 | +100.0% | 0.03% | – |
| CEREW | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $718,000 | -23.8% | 166,666 | 0.0% | 0.02% | -21.1% | |
| IMRA | Sell | IMARA INC | $671,000 | -94.7% | 79,465 | -86.2% | 0.01% | -94.4% |
| NUVBWS | New | NUVATION BIO INC*w exp 07/07/202 | $445,000 | – | 166,666 | +100.0% | 0.01% | – |
| WINT | WINDTREE THERAPEUTICS INC | $49,000 | -52.4% | 20,148 | 0.0% | 0.00% | -50.0% | |
| NEOS | Exit | NEOS THERAPEUTICS INC | $0 | – | -320,993 | -100.0% | -0.00% | – |
| FUSN | Exit | FUSION PHARMACEUTICALS INC | $0 | – | -162,378 | -100.0% | -0.04% | – |
| VCEL | Exit | VERICEL CORP | $0 | – | -64,946 | -100.0% | -0.04% | – |
| MASS | Exit | 908 DEVICES INC | $0 | – | -75,000 | -100.0% | -0.08% | – |
| LGVWWS | Exit | LONGVIEW ACQUISITION CORP*w exp 05/27/202 | $0 | – | -733,333 | -100.0% | -0.10% | – |
| EAR | Exit | EARGO INC | $0 | – | -125,000 | -100.0% | -0.11% | – |
| Exit | BENEFITFOCUS INCnote 1.250%12/1 | $0 | – | -6,500,000 | -100.0% | -0.11% | – | |
| CERE | Exit | CEREVEL THERAPEUTICS HLDNG I | $0 | – | -385,043 | -100.0% | -0.13% | – |
| ARVN | Exit | ARVINAS INC | $0 | – | -75,000 | -100.0% | -0.13% | – |
| PANAU | Exit | PANACEA ACQUISITION CORPunit 99/99/9999 | $0 | – | -500,000 | -100.0% | -0.13% | – |
| TSHA | Exit | TAYSHA GENE THERAPIES INC | $0 | – | -250,000 | -100.0% | -0.13% | – |
| SIEN | Exit | SIENTRA INC | $0 | – | -1,918,118 | -100.0% | -0.15% | – |
| OM | Exit | OUTSET MED INC | $0 | – | -175,000 | -100.0% | -0.20% | – |
| AVRO | Exit | AVROBIO INC | $0 | – | -800,000 | -100.0% | -0.22% | – |
| SRRK | Exit | SCHOLAR ROCK HLDG CORP | $0 | – | -288,876 | -100.0% | -0.28% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -163,000 | -100.0% | -0.28% | – |
| CDAK | Exit | CODIAK BIOSCIENCES INC | $0 | – | -450,000 | -100.0% | -0.29% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -407,000 | -100.0% | -0.29% | – |
| SEM | Exit | SELECT MED HLDGS CORP | $0 | – | -565,000 | -100.0% | -0.31% | – |
| VAPO | Exit | VAPOTHERM INC | $0 | – | -604,520 | -100.0% | -0.32% | – |
| ALGS | Exit | ALIGOS THERAPEUTICS INC | $0 | – | -600,000 | -100.0% | -0.33% | – |
| OXFD | Exit | OXFORD IMMUNOTEC GLOBAL PLC | $0 | – | -1,049,035 | -100.0% | -0.36% | – |
| TARA | Exit | PROTARA THERAPEUTICS INC | $0 | – | -782,670 | -100.0% | -0.37% | – |
| PRAX | Exit | PRAXIS PRECISION MEDICINES I | $0 | – | -350,000 | -100.0% | -0.38% | – |
| OSUR | Exit | ORASURE TECHNOLOGIES INC | $0 | – | -2,124,515 | -100.0% | -0.44% | – |
| Exit | PACIRA BIOSCIENCES INCnote 2.375% 4/0 | $0 | – | -20,000,000 | -100.0% | -0.45% | – | |
| ACCD | Exit | ACCOLADE INC | $0 | – | -638,001 | -100.0% | -0.55% | – |
| STTK | Exit | SHATTUCK LABS INC | $0 | – | -550,000 | -100.0% | -0.57% | – |
| KOD | Exit | KODIAK SCIENCES INC | $0 | – | -202,406 | -100.0% | -0.59% | – |
| Exit | NOVAVAX INCnote 3.750% 2/0 | $0 | – | -25,000,000 | -100.0% | -0.62% | – | |
| NUVA | Exit | NUVASIVE INC | $0 | – | -565,000 | -100.0% | -0.63% | – |
| EDIT | Exit | EDITAS MEDICINE INC | $0 | – | -538,721 | -100.0% | -0.75% | – |
| QDEL | Exit | QUIDEL CORP | $0 | – | -220,000 | -100.0% | -0.78% | – |
| AXNX | Exit | AXONICS MODULATION TECHNOLOG | $0 | – | -800,000 | -100.0% | -0.79% | – |
| Exit | CLOVIS ONCOLOGY INCnote 2.500% 9/1 | $0 | – | -49,064,000 | -100.0% | -0.89% | – | |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -405,386 | -100.0% | -0.90% | – |
| Exit | INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $0 | – | -57,791,000 | -100.0% | -0.90% | – | |
| DFHTU | Exit | DEERFIELD HEALTHCARE TECH ACunit 07/16/2025 | $0 | – | -3,360,000 | -100.0% | -1.00% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -564,067 | -100.0% | -1.01% | – |
| DFPHU | Exit | DFP HEALTHCARE ACQUISITNS COunit 03/31/2025 | $0 | – | -5,000,000 | -100.0% | -1.11% | – |
| OSH | Exit | OAK STR HEALTH INC | $0 | – | -951,063 | -100.0% | -1.15% | – |
| Exit | INSMED INCnote 1.750% 1/1 | $0 | – | -61,000,000 | -100.0% | -1.37% | – | |
| Exit | INSULET CORPnote 0.375% 9/0 | $0 | – | -57,581,000 | -100.0% | -1.51% | – | |
| NKTX | Exit | NKARTA INC | $0 | – | -1,419,872 | -100.0% | -1.72% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -579,248 | -100.0% | -1.79% | – |
| Exit | APELLIS PHARMACEUTICALS INCnote 3.500% 9/1 | $0 | – | -54,825,000 | -100.0% | -1.83% | – | |
| Exit | AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $0 | – | -149,600,000 | -100.0% | -2.71% | – | |
| Exit | NUVASIVE INCnote 2.250% 3/1 | $0 | – | -200,000,000 | -100.0% | -3.98% | – | |
| Exit | INVITAE CORPnote 2.000% 9/0 | $0 | – | -163,385,000 | -100.0% | -5.22% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.